Class I
Terminated
Limbrel500 (flavocoxid and citrated zinc bisglycinate) 500 mg/50 mg capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsdale, AZ 85253; Manufactured by: Cornersto…
Why: Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.
- Company
- Primus Pharmaceuticals, Inc.
Scottsdale, AZ, United States - Reported
- Feb 21, 2018
- Recall started
- Jan 26, 2018
- Ended
- Jul 16, 2019
- Where sold
- Nationwide in the USA.
- Amount
- 160,489 bottles
- Full product description
- Limbrel500 (flavocoxid and citrated zinc bisglycinate) 500 mg/50 mg capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsdale, AZ 85253; Manufactured by: Cornerstone Research and Development, Ogden, UT 84404, NDC 68040-606-16.
- Lots / codes affected
- All lots within expiry.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.